These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 1341005

  • 1. Detection of estrogen receptor in formalin-fixed and paraffin-embedded breast carcinoma: correlation with histological patterns.
    Schmitt FC, Andrade LM, de Lucca LA.
    Rev Paul Med; 1992; 110(4):158-62. PubMed ID: 1341005
    [Abstract] [Full Text] [Related]

  • 2. C-erbB-2 oncoprotein amplification in infiltrating ductal carcinoma of breast relates to high histological grade and loss of oestrogen receptor protein.
    Looi LM, Cheah PL.
    Malays J Pathol; 1998 Jun; 20(1):19-23. PubMed ID: 10879259
    [Abstract] [Full Text] [Related]

  • 3. Flow cytometric analysis of estrogen, progesterone receptor expression and DNA content in formalin-fixed, paraffin-embedded human breast tumors.
    Redkar AA, Krishan A.
    Cytometry; 1999 Apr 15; 38(2):61-9. PubMed ID: 10323218
    [Abstract] [Full Text] [Related]

  • 4. Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Sp gamma in frozen sections or cytosol-based ligand-binding assays.
    Pertschuk LP, Feldman JG, Kim YD, Braithwaite L, Schneider F, Braverman AS, Axiotis C.
    Cancer; 1996 Jun 15; 77(12):2514-9. PubMed ID: 8640700
    [Abstract] [Full Text] [Related]

  • 5. Correlation between histological grade and c-erbB2 oncoprotein overexpression in infiltrating ductal carcinoma of breast.
    Looi LM, Cheah PL, Yap SF.
    Malays J Pathol; 1997 Jun 15; 19(1):35-9. PubMed ID: 10879240
    [Abstract] [Full Text] [Related]

  • 6. [Immunohistochemical study on estrogen receptors in conventionally formalin-fixed, paraffin-embedded tissues of endometrial carcinoma].
    Zhang ZG, Xu MH, Wang MQ.
    Zhonghua Fu Chan Ke Za Zhi; 1994 Nov 15; 29(11):667-9, 699-700. PubMed ID: 7712889
    [Abstract] [Full Text] [Related]

  • 7. Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features.
    Palacios J, Benito N, Pizarro A, Suárez A, Espada J, Cano A, Gamallo C.
    Am J Pathol; 1995 Mar 15; 146(3):605-12. PubMed ID: 7534041
    [Abstract] [Full Text] [Related]

  • 8. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P, Akram M, Benezra R, Brogi E.
    Hum Pathol; 2006 Aug 15; 37(8):1032-41. PubMed ID: 16867866
    [Abstract] [Full Text] [Related]

  • 9. [Human breast cancer embedded in paraffin, fixed in Bouin's fluid. Immunohistochemical analysis of estrogen and progesterone receptors].
    Jacquemier J, Boudaoura T, Martin PM, Torrente M, Hassoun J.
    Ann Pathol; 1991 Aug 15; 11(4):224-30. PubMed ID: 1958256
    [Abstract] [Full Text] [Related]

  • 10. Estrogen receptor beta expression in invasive breast cancer.
    Mann S, Laucirica R, Carlson N, Younes PS, Ali N, Younes A, Li Y, Younes M.
    Hum Pathol; 2001 Jan 15; 32(1):113-8. PubMed ID: 11172304
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
    Linjawi A, Kontogiannea M, Halwani F, Edwardes M, Meterissian S.
    J Am Coll Surg; 2004 Jan 15; 198(1):83-90. PubMed ID: 14698315
    [Abstract] [Full Text] [Related]

  • 12. CD109 expression in basal-like breast carcinoma.
    Hasegawa M, Moritani S, Murakumo Y, Sato T, Hagiwara S, Suzuki C, Mii S, Jijiwa M, Enomoto A, Asai N, Ichihara S, Takahashi M.
    Pathol Int; 2008 May 15; 58(5):288-94. PubMed ID: 18429827
    [Abstract] [Full Text] [Related]

  • 13. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR, Abd-Elwahed SR, Abdulwahed AR.
    Cell Biol Int; 2008 Jun 15; 32(6):698-707. PubMed ID: 18296077
    [Abstract] [Full Text] [Related]

  • 14. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
    Bircan S, Kapucuoglu N, Baspinar S, Inan G, Candir O.
    Pathol Res Pract; 2006 Jun 15; 202(8):569-76. PubMed ID: 16828238
    [Abstract] [Full Text] [Related]

  • 15. [Immunohistochemical investigation of steroid hormones (ER, PR) in breast cancer].
    Mchedlishvili MIu, Gabunia UA, Makharoblidze ER, Burnadze KT, Piradashvili DZ.
    Georgian Med News; 2005 Feb 15; (119):65-7. PubMed ID: 15834186
    [Abstract] [Full Text] [Related]

  • 16. Comparison of heat induced antigen retrieval techniques for immune-histochemical estrogen receptor expression in ductal carcinoma of breast in females.
    Qadir A, Mushtaq S, Sharif MA, Mamoon N, Khadim MT.
    J Coll Physicians Surg Pak; 2010 Aug 15; 20(8):519-23. PubMed ID: 20688016
    [Abstract] [Full Text] [Related]

  • 17. Histological category and expression of hormone receptors in ductal carcinoma in situ of the breast.
    Lebrecht A, Buchmann J, Hefler L, Lampe D, Koelbl H.
    Anticancer Res; 2002 Aug 15; 22(3):1909-11. PubMed ID: 12168892
    [Abstract] [Full Text] [Related]

  • 18. Oestrogen and progesterone receptors in Nigerian breast cancer: relationship to tumour histopathology and survival of patients.
    Ikpatt OF, Ndoma-Egba R.
    Cent Afr J Med; 2003 Aug 15; 49(11-12):122-6. PubMed ID: 15301464
    [Abstract] [Full Text] [Related]

  • 19. Immunohistochemical evaluation of cyclin D1 in breast cancer.
    Bilalović N, Vranić S, Basić H, Tatarević A, Selak I.
    Croat Med J; 2005 Jun 15; 46(3):382-8. PubMed ID: 15861516
    [Abstract] [Full Text] [Related]

  • 20. Comparison of two antibodies for evaluation of estrogen receptors in paraffin-embedded tumors.
    Hendricks JB, Wilkinson EJ.
    Mod Pathol; 1993 Nov 15; 6(6):765-70. PubMed ID: 7508117
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.